Clinical Trial Update: Epigenetic Testing for Breast Cancer Risk Stratification

View source ↗

Summary

The trial evaluated epigenetic testing to stratify breast cancer risk. The study is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Status: COMPLETED